Effects of Pancreatic Kinkinase Combined with Fenofibrate on Serum S1P and LXA4 Expressions in Patients with Diabetic Nephropathy

Effects of Pancreatic Kinkinase Combined with Fenofibrate on Serum S1P and LXA4 Expressions in Patients with Diabetic Nephropathy

ZHANG Longye, LIU Weiping, GUO Yongli, GUAN Renping, SHAO Xue, WANG Shuang

PDF(1015 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1015 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (6) : 966-970. DOI: 10.11748/bjmy.issn.1006-1703.2022.06.016

Clinical Investigation

Effects of Pancreatic Kinkinase Combined with Fenofibrate on Serum S1P and LXA4 Expressions in Patients with Diabetic Nephropathy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(6): 966-970 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.06.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1015 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉